Hologic (FRA:HO1) Total Receivables : €595 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hologic Total Receivables?

Hologic's Total Receivables for the quarter that ended in Mar. 2024 was €595 Mil.

Hologic Total Receivables Historical Data

The historical data trend for Hologic's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic Total Receivables Chart

Hologic Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Receivables

Get a 7-Day Free Trial

589.02

873.54

801.30

623.78

586.19

Hologic Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Receivables	Get a 7-Day Free Trial															666.88	633.92	586.19	615.22	595.33

Hologic Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Hologic Total Receivables Related Terms

Thank you for viewing the detailed overview of Hologic's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hologic (FRA:HO1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (FRA:HO1) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

HOLX:USA HOLX:Mexico HOLX:Austria

Address

250 Campus Drive, Marlborough, MA, USA, 01752

Website

http://www.hologic.com

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic (FRA:HO1) Headlines

No Headlines